Financhill
Sell
14

NRC Quote, Financials, Valuation and Earnings

Last price:
$17.16
Seasonality move :
-3.7%
Day range:
$16.82 - $17.88
52-week range:
$16.74 - $42.18
Dividend yield:
2.8%
P/E ratio:
15.19x
P/S ratio:
2.86x
P/B ratio:
11.64x
Volume:
333.3K
Avg. volume:
104.7K
1-year change:
-56.56%
Market cap:
$403.1M
Revenue:
$148.6M
EPS (TTM):
$1.13
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $128M $133.3M $148M $151.6M $148.6M
Revenue Growth (YoY) 6.93% 4.14% 11.01% 2.44% -1.97%
 
Cost of Revenues $46.4M $49.2M $52.4M $57M $56M
Gross Profit $81.5M $84.1M $95.6M $94.5M $92.6M
Gross Profit Margin 63.72% 63.09% 64.62% 62.36% 62.3%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $33M $34.4M $39M $42.7M $46.6M
Other Inc / (Exp) -$462K $1.1M $4K -$2.7M -$41K
Operating Expenses $38.5M $41.9M $45.3M $48M $52.5M
Operating Income $43M $42.1M $50.3M $46.5M $40M
 
Net Interest Expenses $2.1M $1.8M $1.7M $1M $42K
EBT. Incl. Unusual Items $40.5M $41.5M $48.6M $42.8M $40M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $8.1M $4.2M $11.2M $11M $9M
Net Income to Company $32.4M $37.3M $37.5M $31.8M $31M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $32.4M $37.3M $37.5M $31.8M $31M
 
Basic EPS (Cont. Ops) $1.30 $1.48 $1.47 $1.28 $1.26
Diluted EPS (Cont. Ops) $1.26 $1.45 $1.46 $1.27 $1.25
Weighted Average Basic Share $24.8M $25.2M $25.4M $24.9M $24.5M
Weighted Average Diluted Share $25.7M $25.7M $25.6M $25.1M $24.7M
 
EBITDA $48.1M $50.8M $56.7M $49.3M $46.7M
EBIT $42.6M $43.3M $50.3M $44M $40.8M
 
Revenue (Reported) $128M $133.3M $148M $151.6M $148.6M
Operating Income (Reported) $43M $42.1M $50.3M $46.5M $40M
Operating Income (Adjusted) $42.6M $43.3M $50.3M $44M $40.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $33.5M $37.8M $37.7M $37.9M $35.8M
Revenue Growth (YoY) 3.12% 12.82% -0.2% 0.67% -5.6%
 
Cost of Revenues $12.2M $13.7M $14.5M $14.6M $15.3M
Gross Profit $21.3M $24.1M $23.2M $23.3M $20.5M
Gross Profit Margin 63.59% 63.71% 61.47% 61.44% 57.27%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $8M $9.5M $10.8M $11.8M $11M
Other Inc / (Exp) $627K -$105K $11K -$12K -$12K
Operating Expenses $9.8M $10.9M $12.1M $13.4M $12.5M
Operating Income $11.5M $13.1M $11.1M $10M $8M
 
Net Interest Expenses $449K $409K $273K -- $672K
EBT. Incl. Unusual Items $11.7M $12.6M $10.8M $10M $7.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.1M $3M $2.5M $2.2M $1.6M
Net Income to Company $9.6M $9.7M $8.3M $7.9M $5.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $9.6M $9.7M $8.3M $7.9M $5.7M
 
Basic EPS (Cont. Ops) $0.38 $0.38 $0.34 $0.32 $0.24
Diluted EPS (Cont. Ops) $0.37 $0.38 $0.33 $0.32 $0.24
Weighted Average Basic Share $25.2M $25.4M $24.7M $24.6M $23.7M
Weighted Average Diluted Share $25.7M $25.7M $24.8M $24.7M $23.7M
 
EBITDA $14M $14.4M $12.4M $11.8M $9.5M
EBIT $12.1M $13M $11.1M $10.2M $8M
 
Revenue (Reported) $33.5M $37.8M $37.7M $37.9M $35.8M
Operating Income (Reported) $11.5M $13.1M $11.1M $10M $8M
Operating Income (Adjusted) $12.1M $13M $11.1M $10.2M $8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $131.1M $144.4M $151.7M $148.7M $144.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $47.5M $51M $57.2M $56.2M $56.4M
Gross Profit $83.6M $93.4M $94.5M $92.5M $87.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $33.8M $37.9M $42.1M $46.1M $44.5M
Other Inc / (Exp) $855K $122K -$57K -$2.6M -$42K
Operating Expenses $39.7M $45.8M $47.3M $51.9M $50.5M
Operating Income $43.9M $47.6M $47.2M $40.6M $37.3M
 
Net Interest Expenses $1.8M $1.7M $1.3M -- $2M
EBT. Incl. Unusual Items $43M $46M $45.8M $38M $35.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $5.2M $10M $11M $9.2M $8.2M
Net Income to Company $37.7M $36M $34.8M $28.8M $27.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $37.7M $36M $34.8M $28.8M $27.1M
 
Basic EPS (Cont. Ops) $1.51 $1.41 $1.39 $1.17 $1.13
Diluted EPS (Cont. Ops) $1.47 $1.41 $1.38 $1.16 $1.13
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $50.7M $55.6M $52.4M $44.7M $43.4M
EBIT $44.8M $47.7M $47.2M $38.8M $37.4M
 
Revenue (Reported) $131.1M $144.4M $151.7M $148.7M $144.2M
Operating Income (Reported) $43.9M $47.6M $47.2M $40.6M $37.3M
Operating Income (Adjusted) $44.8M $47.7M $47.2M $38.8M $37.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $98.5M $109.7M $113.4M $110.6M $106.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $36.4M $38.2M $43.1M $42.2M $42.6M
Gross Profit $62.1M $71.5M $70.4M $68.4M $63.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $25.6M $29.1M $32.2M $35.6M $33.5M
Other Inc / (Exp) $987K -$9K -$69K -$28K -$28K
Operating Expenses $30.2M $34.1M $36.1M $40M $38M
Operating Income $32M $37.4M $34.3M $28.3M $25.6M
 
Net Interest Expenses $1.4M $1.3M $889K -- $1.8M
EBT. Incl. Unusual Items $31.6M $36.1M $33.3M $28.5M $23.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.5M $8.3M $8.2M $6.4M $5.6M
Net Income to Company $29M $27.8M $25.2M $22.1M $18.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $29M $27.8M $25.2M $22.1M $18.2M
 
Basic EPS (Cont. Ops) $1.16 $1.09 $1.01 $0.90 $0.77
Diluted EPS (Cont. Ops) $1.13 $1.09 $1.00 $0.89 $0.77
Weighted Average Basic Share $75.3M $76.3M $75.1M $73.7M $71.5M
Weighted Average Diluted Share $77.1M $77M $75.4M $74.1M $71.6M
 
EBITDA $37.6M $42.4M $38.2M $33.6M $30.2M
EBIT $33M $37.4M $34.3M $29.1M $25.7M
 
Revenue (Reported) $98.5M $109.7M $113.4M $110.6M $106.2M
Operating Income (Reported) $32M $37.4M $34.3M $28.3M $25.6M
Operating Income (Adjusted) $33M $37.4M $34.3M $29.1M $25.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $13.5M $34.7M $54.4M $25M $6.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $11.6M $13.9M $13.7M $14.5M $12.4M
Inventory -- -- -- -- --
Prepaid Expenses $2M $2.6M $3.9M $2.4M $4.2M
Other Current Assets $1.9M $1.6M $982K $1.1M $940K
Total Current Assets $29.2M $54.1M $73.7M $43.7M $24.4M
 
Property Plant And Equipment $15.2M $13M $13.4M $17.8M $30.3M
Long-Term Investments -- -- -- -- --
Goodwill $57.9M $57.3M $61.6M $61.6M $61.6M
Other Intangibles $1.7M $1.4M $1.8M $1.6M $1.5M
Other Long-Term Assets $2.5M $3.1M $3.3M $3.3M $3.3M
Total Assets $110.7M $133.4M $157.5M $130.5M $122.4M
 
Accounts Payable $1.3M $1.1M $1.9M $1.2M $1.3M
Accrued Expenses $9.5M $9.6M $12.6M $8.5M $8.8M
Current Portion Of Long-Term Debt $4.4M $4.1M $4.3M $4.5M $7.2M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1M $1.3M $1.3M $1.1M $880K
Total Current Liabilities $38.2M $31.7M $40.4M $33.4M $36.2M
 
Long-Term Debt $29.8M $26.5M $22.3M $17.7M $29.5M
Capital Leases -- -- -- -- --
Total Liabilities $77.8M $69.1M $72.2M $58.4M $73.5M
 
Common Stock $30K $31K $31K $31K $31K
Other Common Equity Adj -$2.2M -$2.4M -$2.4M -- --
Common Equity $32.9M $64.3M $85.3M $72M $49M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $32.9M $64.3M $85.3M $72M $49M
 
Total Liabilities and Equity $110.7M $133.4M $157.5M $130.5M $122.4M
Cash and Short Terms $13.5M $34.7M $54.4M $25M $6.7M
Total Debt $34.2M $30.6M $26.5M $22.2M $36.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $21.9M $52.5M $28.4M $3.8M $3.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $17.4M $16.3M $15.4M $14.5M $11.1M
Inventory -- -- -- -- --
Prepaid Expenses $2.6M $2.9M $3.6M $5.7M $4.9M
Other Current Assets $1.9M $1M $1.4M $369K $664K
Total Current Assets $47.4M $72.7M $49.1M $24.7M $20.7M
 
Property Plant And Equipment $13.5M $12.5M $16.4M $26.8M $36.3M
Long-Term Investments -- -- -- -- --
Goodwill $57.9M $61.6M $61.6M $61.6M $66.2M
Other Intangibles $1.5M $1.9M $1.7M $1.5M $2.7M
Other Long-Term Assets $2.5M $3.3M $3.4M $3.9M $5.9M
Total Assets $127.2M $156.2M $135M $120.1M $131.8M
 
Accounts Payable $725K $961K $1.1M $1.4M $2.6M
Accrued Expenses $8.8M $9.8M $10.7M $9.6M $11.7M
Current Portion Of Long-Term Debt $4M $4.2M $4.4M $4.7M $3.7M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.2M $1.3M $1.3M $899K $1.2M
Total Current Liabilities $32.1M $39.2M $41.1M $40.8M $44.3M
 
Long-Term Debt $27.6M $23.4M $18.8M $14.2M $44.9M
Capital Leases -- -- -- -- --
Total Liabilities $70.5M $73.1M $67.2M $62.3M $97.2M
 
Common Stock $31K $31K $31K $31K $31K
Other Common Equity Adj -$2.6M -$2.4M -$2.6M -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $56.7M $83.1M $67.8M $57.9M $34.6M
 
Total Liabilities and Equity $127.2M $156.2M $135M $120.1M $131.8M
Cash and Short Terms $21.9M $52.5M $28.4M $3.8M $3.5M
Total Debt $31.6M $27.6M $23.3M $23.8M $53.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $32.4M $37.3M $37.5M $31.8M $31M
Depreciation & Amoritzation $5.5M $7.5M $6.4M $5.3M $5.9M
Stock-Based Compensation $1.2M $680K $623K $1.2M $935K
Change in Accounts Receivable $311K -$2.3M $343K -$733K $2.1M
Change in Inventories -- -- -- -- --
Cash From Operations $40.9M $40.6M $46.3M $36.3M $38.1M
 
Capital Expenditures $4.7M $4M $5.5M $9.8M $15.8M
Cash Acquisitions -- -- -$3M -- --
Cash From Investing -$4.7M -$3.7M -$8.5M -$9.8M -$15.8M
 
Dividends Paid (Ex Special Dividend) -$31.3M -$10.5M -$9.2M -$21M -$36.4M
Special Dividend Paid
Long-Term Debt Issued $21M -- -- -- $34M
Long-Term Debt Repaid -$24.9M -$3.9M -$4.6M -$4.8M -$19.8M
Repurchase of Common Stock -- -- -$4.1M -$27.6M -$19.1M
Other Financing Activities -$1.1M -$2.8M -$721K -$2.2M -$8K
Cash From Financing -$36.3M -$15.5M -$18.2M -$55.6M -$40.7M
 
Beginning Cash (CF) $13M $13.5M $34.7M $54.4M $25M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$85K $21.4M $19.7M -$29.2M -$18.4M
Ending Cash (CF) $13.5M $34.7M $54.4M $25M $6.7M
 
Levered Free Cash Flow $36.3M $36.7M $40.8M $26.4M $22.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $9.6M $9.7M $8.3M $7.9M $5.7M
Depreciation & Amoritzation $1.8M $1.4M $1.3M $1.6M $1.5M
Stock-Based Compensation $274K $126K $291K $68K $189K
Change in Accounts Receivable $1.6M -$2.1M -$2.3M -$2.6M -$569K
Change in Inventories -- -- -- -- --
Cash From Operations $10.5M $8.7M $10.1M $9.8M $9.4M
 
Capital Expenditures $1M $992K $4M $4.5M $1.6M
Cash Acquisitions -- -- -- -- -$4.8M
Cash From Investing -$748K -$992K -$4M -$4.5M -$6.4M
 
Dividends Paid (Ex Special Dividend) -- -$3.1M -$5.9M -$27.5M -$2.9M
Special Dividend Paid -- -- -- $1M --
Long-Term Debt Issued -- -- -- $5M $32.5M
Long-Term Debt Repaid -$1M -$1.1M -$1.2M -$1.2M -$21.1M
Repurchase of Common Stock -- -- -$3.1M -$309K -$8.5M
Other Financing Activities -$36K -$1K -$190K -$8K -$37K
Cash From Financing -$20K -$4.1M -$10.5M -$24M -$17K
 
Beginning Cash (CF) $12M $48.9M $33M $22.5M $485K
Foreign Exchange Rate Adjustment $150K -$69K -$176K -- --
Additions / Reductions $9.7M $3.7M -$4.4M -$18.7M $3M
Ending Cash (CF) $21.9M $52.5M $28.4M $3.8M $3.5M
 
Levered Free Cash Flow $9.5M $7.7M $6.1M $5.3M $7.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $37.7M $36M $34.8M $28.8M $27.1M
Depreciation & Amoritzation $5.9M $7.9M $5.3M $5.8M $5.9M
Stock-Based Compensation $1.1M $208K $1.3M $967K $354K
Change in Accounts Receivable -$3.1M $2.3M $876K $916K $3.8M
Change in Inventories -- -- -- -- --
Cash From Operations $36.4M $50.5M $40.2M $34.5M $40M
 
Capital Expenditures $3.7M $5.3M $9.6M $14M $14.8M
Cash Acquisitions -- -$3M -- -- -$4.8M
Cash From Investing -$3.4M -$8.3M -$9.6M -$14M -$19.6M
 
Dividends Paid (Ex Special Dividend) -$15.3M -$6.1M -$18.1M -$39.3M -$11.6M
Special Dividend Paid
Long-Term Debt Issued -- -- -- $5M $85M
Long-Term Debt Repaid -$3.7M -$4.6M -$4.7M -$4.9M -$55.2M
Repurchase of Common Stock -- -- -$29.4M -$6.4M -$38.5M
Other Financing Activities -$2M -$1.4M -$2.4M -- -$354K
Cash From Financing -$19.4M -$11.6M -$54.5M -$45.1M -$20.7M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $13.6M $30.5M -$23.9M -$24.6M -$366K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $32.7M $45.1M $30.6M $20.5M $25.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $29M $27.8M $25.2M $22.1M $18.2M
Depreciation & Amoritzation $4.6M $5M $3.9M $4.5M $4.5M
Stock-Based Compensation $747K $275K $910K $677K $96K
Change in Accounts Receivable -$6.7M -$2.2M -$1.7M -$6K $1.8M
Change in Inventories -- -- -- -- --
Cash From Operations $24.4M $34.3M $28.2M $26.4M $28.2M
 
Capital Expenditures $2.4M $3.8M $7.9M $12M $11M
Cash Acquisitions -- -$3M -- -- -$4.8M
Cash From Investing -$2.2M -$6.8M -$7.9M -$12M -$15.8M
 
Dividends Paid (Ex Special Dividend) -$10.5M -$6.1M -$15M -$33.4M -$8.6M
Special Dividend Paid -- -- -- $1M --
Long-Term Debt Issued -- -- -- $5M $56M
Long-Term Debt Repaid -$2.8M -$3.4M -$3.6M -$3.7M -$39.1M
Repurchase of Common Stock -- -- -$25.3M -$4.1M -$23.5M
Other Financing Activities -$1.9M -$461K -$2.1M -$8K -$354K
Cash From Financing -$13.6M -$9.7M -$46M -$35.6M -$15.6M
 
Beginning Cash (CF) $35.5M $127M $134.6M $71.2M $8.8M
Foreign Exchange Rate Adjustment -$324K -$1K -$224K -- --
Additions / Reductions $8.7M $17.8M -$25.7M -$21.2M -$3.2M
Ending Cash (CF) $43.8M $144.8M $108.7M $50M $5.6M
 
Levered Free Cash Flow $22M $30.5M $20.3M $14.4M $17.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock